Correction: Barriers and facilitators to the implementation of a new European eHealth solution (SurPass v2.0): the PanCareSurPass Open Space study.

Autor: de Beijer IAE; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, The Netherlands. i.a.e.debeijer-3@prinsesmaximacentrum.nl., Hardijzer EC; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, The Netherlands., Haupt R; IRCCS Istituto Giannina Gaslini, Genoa, Italy., Grabow D; Division of Childhood Cancer Epidemiology, German Childhood Cancer Registry, Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI), University Medical Center, of the Johannes Gutenberg University Mainz, Mainz, Germany., Balaguer J; Hospital Universitario y Politécnico La Fe, Valencia, Spain., Bardi E; St. Anna Children's Hospital, Vienna, Austria.; Department of Paediatrics and Adolescent Medicine, Johannes Kepler University Linz, Kepler University Hospital, Linz, Austria., Nieto AC; Hospital Universitario y Politécnico La Fe, Valencia, Spain., Ciesiūniene A; Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania., Düster V; St. Anna Children's Hospital and Children's Cancer Research Institute, Department of Studies and Statistics for Integrated Research and Projects, Department of Paediatrics, Medical University of Vienna, Vienna, Austria., Filbert AL; Division of Childhood Cancer Epidemiology, German Childhood Cancer Registry, Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI), University Medical Center, of the Johannes Gutenberg University Mainz, Mainz, Germany., Gsell H; CCI Europe, Vienna, Austria., Kapitančukė M; Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania., Ladenstein R; St. Anna Children's Hospital and Children's Cancer Research Institute, Department of Studies and Statistics for Integrated Research and Projects, Department of Paediatrics, Medical University of Vienna, Vienna, Austria., Langer T; Universitatsklinikum Schleswig-Holstein, Campus Lubeck, Lübeck, Germany., Muraca M; IRCCS Istituto Giannina Gaslini, Genoa, Italy., van den Oever SR; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, The Netherlands., Prikken S; University Hospitals Leuven, KU Leuven, Louvain, Belgium., Rascon J; Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania., Tormo MT; Instituto de Investigación Sanitaria La Fe, Valencia, Spain., Uyttebroeck A; University Hospitals Leuven, KU Leuven, Louvain, Belgium., Vercruysse G; University Hospitals Leuven, KU Leuven, Louvain, Belgium., van der Pal HJH; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, The Netherlands., Kremer LCM; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, The Netherlands.; University Medical Center Utrecht, Wilhelmina Children's Hospital, Utrecht, the Netherlands.; Department of Pediatrics, Emma Children's Hospital, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Pluijm SMF; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, The Netherlands.

Publikováno v: Journal of cancer survivorship : research and practice [J Cancer Surviv] 2024 Mar 11. Date of Electronic Publication: 2024 Mar 11.